Date Initiated by Firm |
May 09, 2016 |
Create Date |
June 15, 2016 |
Recall Status1 |
Terminated 3 on March 28, 2017 |
Recall Number |
Z-2002-2016 |
Recall Event ID |
74341 |
Product Classification |
Tubing, pump, cardiopulmonary bypass - Product Code DWE
|
Product |
Small Patient ECC Pack, REF BEQ-TOP 24100, Product Usage: The HLM Tubing Sets with Bioline Coating are for single use only. They may be sold sterile, non-sterile and bulk packed. Custom tubing sets that are sold sterile are not to be re-sterilized by the user. In open heart surgery the HLM Tubing Sets with Bioline Coating are used in combination with the heart-lung machine for the oxygenation of blood and removal of carbon dioxide. The main purpose of the HLM Tubing Sets with Bioline Coating is to connect the patient to the hear-lung machine and its components. The HLM Tubing Sets with Bioline Coating are therefore a component in the extracorporeal perfusion circulation system. The utilization period of the use of the tubing sets is restricted to six hours
|
Code Information |
Lot/batch No: 3000003260, Part number 701050175 |
Recalling Firm/ Manufacturer |
Datascope Corporation 15 Law Dr Fairfield NJ 07004-0011
|
For Additional Information Contact |
Ms. Karen LeFevere 973-709-7652
|
Manufacturer Reason for Recall |
Custom Tubing Set BEQ-TOP-24100 (Small Patient ECC Pack) was identified as possessing a level of endotoxin that exceeded the regulatory limits.
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
Maquet sent via express mail and hand delivered a recall letter and response form dated May 9, 2016 to their sole customer. |
Quantity in Commerce |
17 units |
Distribution |
US in the state of GA |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|